{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:03:56Z","timestamp":1784178236182,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liver transplantation is a life-saving treatment for end-stage liver disease, but long-term outcomes are limited by complications of lifelong immunosuppression. Inducing immune tolerance has become a major research priority. Tryptophan (Trp) metabolism, particularly the kynurenine pathway, is a key endogenous regulator of peripheral tolerance. This review moves beyond a simple description of metabolic routes and provides a critical, integrated analysis. We systematically compare the non\u2212redundant immunosuppressive roles of indoleamine 2,3\u2212dioxygenase (IDO) and tryptophan 2,3\u2212dioxygenase (TDO2) in liver transplant immunity, dissect the Trp\/kynurenine\/AhR pathways that reprograms immune cell function, and incorporate gut\u2212microbiota\u2212dependent indole metabolism as an upstream gut\u2212liver axis node. Clinical evidence is stratified by level, and major translational barriers, including safety risks, delivery challenges, and lack of validated biomarkers are discussed. Current data suggest that combined metabolite panels may outperform single markers, but therapeutic targeting of Trp metabolism remains a preclinical research direction rather than an established therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1873690","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:50Z","timestamp":1784175710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tryptophan metabolism in liver transplantation immune tolerance"],"prefix":"10.3389","volume":"17","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL clinical practice guidelines on liver transplantation","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2024.01176","article-title":"Recent trends and new developments in liver transplantation","volume":"18","author":"Sugawara","year":"2024","journal-title":"Biosci Trends"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2022.08.001","article-title":"Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma","volume":"6","author":"Guan","year":"2022","journal-title":"Liv Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.535012","article-title":"Clinical and basic research progress on Treg-induced immune tolerance in liver transplantation","volume":"12","author":"Ni","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/phar.2495","article-title":"Immunosuppression considerations in simultaneous organ transplant","volume":"41","author":"Kovac","year":"2021","journal-title":"Pharmacotherapy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp Mol Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104657","article-title":"Immunomodulatory mechanisms driving tumor escape in glioblastoma: the central role of IDO and tryptophan metabolism in local and systemic immunotolerance","volume":"209","author":"Gagliardi","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030968","article-title":"Role of kynurenine and its derivatives in liver diseases: recent advances and future clinical perspectives","volume":"26","author":"Tan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13093","article-title":"No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients","volume":"192","author":"Bigenzahn","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"18663","DOI":"10.1038\/s41598-022-18957-4","article-title":"Metabolomics profiling in acute liver transplant rejection in a pediatric population","volume":"12","author":"Frediani","year":"2022","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1632446","article-title":"IDO and TDO inhibitors in cancer immunotherapy: mechanisms, clinical development, and future directions","volume":"16","author":"Al-Zoubi","year":"2025","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.5c00329","article-title":"Dual inhibition of IDO1 and TDO: a unified therapeutic strategy to combat Alzheimer's disease and cancer","volume":"16","author":"Khamle","year":"2025","journal-title":"ACS Chem Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","article-title":"Tryptophan and indole metabolism in immune regulation","volume":"70","author":"Fiore","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/11786469241248287","article-title":"A review of the evidence for tryptophan and the kynurenine pathway as a regulator of stem cell niches in health and disease","volume":"17","author":"Summers","year":"2024","journal-title":"Int J Tryptophan Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-026-07758-2","article-title":"IDO family: the metabolic crossroads connecting immunity, nerves and tumors","volume":"24","author":"Wang","year":"2026","journal-title":"J Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0169-4","article-title":"The kynurenine pathway is involved in bacterial meningitis","volume":"11","author":"Coutinho","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1125634","article-title":"The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(00)02792-5","article-title":"Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts","volume":"33","author":"Miki","year":"2001","journal-title":"Transplant Proc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.08.001","article-title":"Induction of indoleamine 2,3-dioxygenase in livers following hepatectomy prolongs survival of allogeneic hepatocytes after transplantation","volume":"40","author":"Lin","year":"2008","journal-title":"Transplant Proc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21662","article-title":"Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection","volume":"15","author":"Laurence","year":"2009","journal-title":"Liv Transpl"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15024","article-title":"Mechanism of indoleamine 2, 3-dioxygenase inhibiting cardiac allograft rejection in mice","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.01.033","article-title":"Dynamic changes of indoleamine 2,3-dioxygenase of Kupffer cells in rat liver transplant rejection and tolerance","volume":"44","author":"Luan","year":"2012","journal-title":"Transplant Proc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05036.x","article-title":"Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance","volume":"23","author":"Lin","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000005386","article-title":"TDO2 deficiency exacerbates the immune rejection response in rat liver transplantation via the Kyn-AHR axis","volume":"109","author":"Li","year":"2025","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104171","article-title":"A novel photosensitizer-based photodynamic therapy reprograms the kynurenine-AhR axis to boost antitumor immunity in breast cancer","volume":"93","author":"Liu","year":"2026","journal-title":"Redox Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202508107","article-title":"Regulating tumor metabolic reprogramming with biomimetic co-delivery of simvastatin and kynureninase for immunotherapy","volume":"13","author":"Yin","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120371","article-title":"Wumei Wan remodels the tumor immune microenvironment via the Ido1-KYN-AHR axis in AOM\/DSS-induced colorectal cancer model","volume":"353","author":"Zhang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9681-4","article-title":"IDO-competent-DCs induced by IFN-\u03b3 attenuate acute rejection in rat liver transplantation","volume":"32","author":"Sun","year":"2012","journal-title":"J ClinImmunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01089-1","article-title":"Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma","volume":"22","author":"Lau","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2023.127392","article-title":"Indole metabolites and colorectal cancer: gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms","volume":"272","author":"Liu","year":"2023","journal-title":"Microbiol Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2470386","DOI":"10.1007\/978-3-319-67199-4_101571","article-title":"Indole derivatives ameliorated the methamphetamine-induced depression and anxiety via aryl hydrocarbon receptor along \"microbiota-brain\" axis","volume":"17","author":"Wang","year":"2025","journal-title":"Gut Microbes"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01339-x","article-title":"Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut\u2013liver axis","volume":"22","author":"Luo","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8565","DOI":"10.1038\/s41467-025-63611-y","article-title":"Effect of the gut microbiota-derived tryptophan metabolite indole-3-acetic acid in pneumonia","volume":"16","author":"Kullberg","year":"2025","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0b013e3181b72e49","article-title":"Is indoleamine 2,3-dioxygenase important for graft acceptance in highly sensitized patients after combined auxiliary liver-kidney transplantation","volume":"88","author":"Ingelsten","year":"2009","journal-title":"Transplantation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2010.08.013","article-title":"Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection","volume":"71","author":"Lahdou","year":"2010","journal-title":"Hum Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002023","article-title":"Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation","volume":"71","author":"Brandacher","year":"2007","journal-title":"Kidney Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2020.101351","article-title":"Soluble CD83 inhibits acute rejection by up regulating TGF-\u03b2 and IDO secretion in rat liver transplantation","volume":"64","author":"Xiong","year":"2021","journal-title":"Transpl Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000005391","article-title":"Harnessing TDO2-mediated metabolism to modulate immune rejection in liver transplantation","volume":"109","author":"Maluf","year":"2025","journal-title":"Transplantation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.08.004","article-title":"Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization","volume":"17","author":"Xu","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2018.1483674","article-title":"Regulatory T cells in paracoccidioidomycosis","volume":"10","author":"Calich","year":"2019","journal-title":"Virulence"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nri2163","article-title":"IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation","volume":"7","author":"Puccetti","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01489.x","article-title":"Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice","volume":"49","author":"Lehrmann","year":"2008","journal-title":"Epilepsia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109282","article-title":"DSS-induced acute colitis causes dysregulated tryptophan metabolism in brain: an involvement of gut microbiota","volume":"115","author":"Zhao","year":"2023","journal-title":"J Nutr Biochem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.crc-23-0513","article-title":"Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression","volume":"4","author":"Crump","year":"2024","journal-title":"Cancer Res Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:51Z","timestamp":1784175711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2026.1873690"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1873690","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1873690"}}